A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece (RETRO-TAS)

Hellenic Study Group of Psychoneuroimmunology in Cancer

Status: Completed

Conditions: Metastatic Colorectal Cancer

Treatments: Drug: Trifluridine/Tipiracil

Study type: Observational

Funder types: NETWORK; Industry

Identifiers

NCT04965870

2021-01

Details and patient eligibility

About

Collection of real world data on the clinical efficacy of trifluridine/ tipiracil (FTD/TPI) in the Greek population.

Full description

The aim of this analysis is to record clinical practice and to collect real world data on the clinical efficacy of trifluridine/ tipiracil (FTD/TPI) in the Greek population. Main objectives include to assess physician's choice of treatment in chemoresistant metastatic colorectal cancer with FTD/TPI in third line and beyond In addition, the clinicopathologic features related to metastatic colorectal cancer (focus on molecular profile), duration of treatment, dose modification and toxicity will be analyzed.

Enrollment: 200 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years
• Histologically confirmed metastatic colorectal cancer
• Available data on previous chemotherapy lines

Exclusion criteria

No exclusion criteria have been established for this observational and retrospective study.